SEO

LAC Stock Price Up Almost 300% Since March Low; Receives $40 Million In Cash

LAC Stock Price Up Almost 300% Since March Low; Receives $40 Million In Cash

Since bottoming out at $1.92 in March 2020, shares of Lithium Americas (LAC) rocketed to a recent high of $5.78.  All because there’s a potential lithium supply shortage. According to Reuters, “A new demand surge is already looming in the form of the multiple ‘green stimulus’ packages as governments try and kick-start locked-down economies. You don’t […]

MSI Develops SaferWatch Systems for Education Facilities as Calls Grow to Remove Police from Schools

MSI Develops SaferWatch Systems for Education Facilities as Calls Grow to Remove Police from Schools

With two current themes impacting school safety, one the COVID-19 pandemic and a call in some school districts to remove police officers from schools, Motorola Solutions (MSI) is working to improve school safety. MSI has teamed with SaferWatch to implement a security system that provides schools with a “mobile panic button” that can be used […]

PFE Stock Price Jumps on Announcement of $1.95 Billion Payout From U.S. For COVID-19 Vaccine

PFE Stock Price Jumps on Announcement of $1.95 Billion Payout From U.S. For COVID-19 Vaccine

Pfizer (PFE) just announced the U.S. government will pay $1.95 billion for PFE to produce and deliver 100 million doses of its COVID vaccine once the U.S. declares it’s safe and effective. Under the agreement, the U.S. can acquire an additional 500 million doses from PFE. “Through Operation Warp Speed, we are assembling a portfolio of vaccines […]

OMI Stock Price Jumps on Raised Income Projections

OMI Stock Price Jumps on Raised Income Projections

Owens & Minor (OMI) had been flying under Wall Street’s radar until it preannounced earnings this week.  The medical supplies provider told the market it is essentially doubling its previous adjusted net income guidance. OMI raised projections for net income from $0.50 to $0.60 for the year to between $1.00 and $1.20. OMI said it […]

FATE Stock Price Jumps on License Agreement with Baylor College for Rejection-Resistant Cellular Therapies

FATE Stock Price Jumps on License Agreement with Baylor College for Rejection-Resistant Cellular Therapies

Since bottoming out in March 2020, Fate Therapeutics (FATE) has run from a low of $19.91 to a current price of $35.50 with plenty of catalysts. For one, FATE just entered into an exclusive license agreement with Baylor College of Medicine covering alloimmune defense receptors, a first-in-class approach that renders off-the-shelf allogeneic cell products resistant […]